Clinical Trials Sponsored by Novosanis NV

Total 334 results

Gilead Sciences
Ono Pharmaceutical Co. Ltd; Galapagos NV

Completed

Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome

Sjogren's Syndrome

United States, Spain, United Kingdom, Poland
Janssen-Cilag International NV
Alza Corporation, DE, USA

Completed

A Study to Compare Patient-controlled Pain Medications Delivered Either Through the Skin or Intravenously (EuroTrans)

Pain | Pain, Postoperative | Analgesia, Patient-Controlled

France, United Kingdom, Germany, Spain, Switzerland, Sweden, Belgium, Austria, Denmark, Ireland
European Institute of Oncology
Janssen-Cilag International NV

Active, not recruiting

CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER

Breast Cancer

Italy
Cosmo Artificial Intelligence-AI Ltd

Completed

Polyp REcognition Assisted by a Device Interactive Characterization Tool - The PREDICT Study (PREDICT)

Artificial Intelligence

Italy
Hellenic Society of Hematology
Takeda; Janssen Pharmaceutica NV

Unknown

Safety and Efficacy of Daratumumab in Combination With Ixazomib and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma (DARIA)

Multiple Myeloma

Greece
SGS Life Sciences, a division of SGS Belgium NV

Completed

A Study to Determine the Safety and Attack Rate of the Seasonal Flu in Healthy Volunteers

Influenza, Human
University Hospital, Antwerp
FLUIDDA nv; Artesis University College, Antwerp

Unknown

Effects of IPV Assessed With Functional Imaging (IPV)

Chronic Obstructive Pulmonary Disease

Belgium
University College, London
Novartis; Cancer Research UK; Janssen Pharmaceutica NV

Not yet recruiting

A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer (STAMPEDE2)

Prostate Cancer Metastatic
Academisch Medisch Centrum - Universiteit van Amsterdam...
Galapagos NV

Active, not recruiting

Early Intestinal Ultrasound in Predicting Treatment Response to Filgotinib in Ulcerative Colitis (STEER)

Ulcerative Colitis

Netherlands
University Hospital, Ghent
Universitaire Ziekenhuizen KU Leuven; Pilipili NV; Imec

Withdrawn

EEG@HOME (Phase 4 of the Project)

Epilepsy

Belgium
Genfit
SGS Life Sciences, a division of SGS Belgium NV

Completed

Mass Balance Study of 14C-labelled GFT505 in Healthy Volunteers

Healthy

Belgium
Johnson & Johnson Pharmaceutical Research & Development...
Janssen-Cilag International NV

Completed

Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure (PRIMS)

Chronic Kidney Failure | Pure Red-Cell Aplasia

Poland, United Kingdom, Belgium, Germany, Spain, Portugal, Australia, Switzerland, Finland, Greece, Sweden, Netherlands, Norway, Ireland, Denmark
Johnson & Johnson Pharmaceutical Research & Development...
Janssen-Cilag International NV

Completed

A Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia.

Schizophrenia

United States, Ukraine, Romania, South Africa, Taiwan, Korea, Republic of, Russian Federation, Costa Rica, Mexico
Montefiore Medical Center
M.D. Anderson Cancer Center; Flamingo Therapeutics NV

Recruiting

Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML

Acute Myeloid Leukemia | Myelodysplastic Syndromes | AML/MDS

United States
Cytoki Pharma
SGS Life Sciences, a division of SGS Belgium NV

Completed

A Phase 1 Study to Investigate Safety, Tolerability, and Pharmacokinetics of CK-0045 in Healthy Participants and Otherwise Healthy Participants With Obesity

Healthy

Belgium
Psyadon Pharma
SGS Life Sciences, a division of SGS Belgium NV

Completed

Effect of Thiamphenicol on EAAT2 and Other Biomarkers From Nasal Biopsied Tissue

Healthy

Belgium
Eloxx Pharmaceuticals, Inc.
SGS Life Sciences, a division of SGS Belgium NV

Completed

Phase 1 Study of ELX-02 in Healthy Adults

Genetic Disease | Nonsense Mutation

Belgium
Vicore Pharma AB
SGS Life Sciences, a division of SGS Belgium NV

Completed

Cold Challenge With C21 in RP

Systemic Sclerosis | Raynaud Phenomenon

United Kingdom
Eloxx Pharmaceuticals, Inc.
SGS Life Sciences, a division of SGS Belgium NV

Completed

Phase 1 Study of ELX-02 in Healthy Adult Subjects

Genetic Disease | Nonsense Mutation

Belgium
Pierre Fabre Medicament
SGS Life Sciences, a division of SGS Belgium NV

Completed

Safety, Preliminary Pharmacokinetics and Bronchodilator Properties of V0162

Chronic Obstructive Pulmonary Disease

Belgium, France
Atriva Therapeutics GmbH
SGS Life Sciences, a division of SGS Belgium NV

Completed

Phase 1 Study of ATR-002

Influenza

Belgium
R.Bos
Leiden University Medical Center; Galapagos NV; Medical Centre Leeuwarden

Recruiting

Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH) (BACH)

Rheumatoid Arthritis

Netherlands
Cliniques universitaires Saint-Luc- Université...
University Hospital, Ghent; Janssen-Cilag International NV

Completed

TNF and IL23 Blocking Agents Gene Expression Ratios in the Psoriatic Arthritis Synovium_(TIGERS) Study (TIGERS)

Psoriatic Arthritis

Belgium
University Hospital, Antwerp
University of Padova; Campus Bio-Medico University; Université Montpellier; Indigo...

Completed

cArdiopulmonary exerCise Test Assessing Multiple bIOmarkers iN Type 1 Diabetes

Diabetes Mellitus, Type 1

Belgium
Precigen Actobio T1D, LLC
TFS Trial Form Support; Intrexon Actobiotics NV, d/b/a Precigen Actobio

Completed

A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recently Diagnosed Type 1 Diabetes Mellitus (T1D)

Diabetes Mellitus, Type 1

United States, Belgium
Epihunter NV
KU Leuven; Boston Children's Hospital; Filadelfia Epilepsy Hospital; Institute...

Completed

ECV - Epihunter Clinical Validation (ECV)

Absence Epilepsy | Absence Seizures

Belgium, United States, Denmark, Georgia
University Hospital Heidelberg
German Cancer Research Center; Janssen-Cilag International NV; inVentiv Health... and other collaborators

Completed

Bendamustine, Prednisone and Velcade® for First-line Treatment of Patients With Symptomatic Multiple Myeloma (BPV)

Multiple Myeloma

Germany
N-Gene Research Laboratories, Inc.
Thermo Fisher Scientific, Inc; Integrium; Msource Medical Development GmbH; Kinexum... and other collaborators

Terminated

Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus

United States, Germany, Hungary
University Hospital, Antwerp
Karolinska Institutet; Erasmus Medical Center; University of California, San... and other collaborators

Completed

CENTER-TBI: Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI)

Traumatic Brain Injury

Germany, Norway, United Kingdom, Belgium, Netherlands, Denmark, Finland, Sweden, France, Switzerland, Israel, Spain, Austria, Serbia, Latvia, Hungary, Italy, Lithuania, Romania
University of Southampton
NIHR Clinical Research Facility, University Hospital Southampton NHS Foundation... and other collaborators

Terminated

High-Dose Melphalan With or Without Radiolabeled Monoclonal Antibody in Treating Patients With Multiple Myeloma Undergoing an Autologous Stem Cell Transplant (AntiCD-66)

Multiple Myeloma and Plasma Cell Neoplasm

United Kingdom
María de los Ángeles Tena Pajuelo
Orion Corporation, Orion Pharma; Canary Foundation; Dr Negrin Hospital Statistician and other collaborators

Unknown

Spanish Randomized Clinical Trial to Compare Levosimendan Versus Placebo in Postoperative Cardiac Surgery (SPARTANS) (SPARTANS)

Cardiac Output, Low

Spain
Medicines for Malaria Venture
Sanaria Inc.; Institute of Tropical Medicine, Belgium; Iqvia Pty Ltd; SGS Life... and other collaborators

Completed

Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites

Protozoan Infections | Parasitemia | Malaria,Falciparum | Parasitic Disease

Belgium
Simmaron Research Inc.
Center For Complex Diseases-Seattle, WA; Sierra Internal Medicine, Incline... and other collaborators

Enrolling by invitation

Rapamycin in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

Myalgic Encephalomyelitis

United States
Medicines for Malaria Venture
Washington University School of Medicine; Sanaria Inc.; Institute of Tropical... and other collaborators

Completed

Safety, Tolerability and Chemoprotective Activity of P218 in PfSPZ Challenge Model

Malaria

Belgium

Clinical Trials Sponsored by Novosanis NV

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations